<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th></th>
      <th>HGNC</th>
    </tr>
    <tr>
      <th>diseases</th>
      <th>haging</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th rowspan="7" valign="top">Alzheimer disease</th>
      <th>accumulation of reactive oxygen species</th>
      <td>NOS3</td>
    </tr>
    <tr>
      <th>changes in the extracellular matrix structure</th>
      <td>ADAM10</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>PLAU,PSEN1,ADAM10,BLMH,ACE</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>NOS3</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>APOE,ADAM10</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>A2M,ACE</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>A2M</td>
    </tr>
    <tr>
      <th rowspan="7" valign="top">Amyotrophic lateral sclerosis</th>
      <th>accumulation of reactive oxygen species</th>
      <td>SOD1</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>VCP,SQSTM1</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>SQSTM1</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>HNRNPA1</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>VCP</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>TBK1</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>SQSTM1,FUS</td>
    </tr>
    <tr>
      <th rowspan="3" valign="top">Bleeding disorder, platelet-type</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>ITGB3</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>PLAU</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>TBXA2R</td>
    </tr>
    <tr>
      <th rowspan="16" valign="top">Breast cancer</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>AKT1,PIK3CA</td>
    </tr>
    <tr>
      <th>TOR pathway dysregulation</th>
      <td>ATM,AKT1,PIK3CA</td>
    </tr>
    <tr>
      <th>accumulation of reactive oxygen species</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>alterations in DNA methylation</th>
      <td>BRCA1,PPM1D,PIK3CA</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>ATM,BRCA1,BRCA2,RAD51</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>TP53,ESR1,PPM1D</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>AKT1,BRCA1</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>TP53,AKT1</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>TP53,PPM1D,KRAS</td>
    </tr>
    <tr>
      <th>mitochondrial DNA instability</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>TP53,ATM,NBN,BRCA1,BRCA2,RAD51</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>TP53,ATM,BRCA2</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>TP53,ESR1</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>AKT1</td>
    </tr>
    <tr>
      <th>telomere attrition</th>
      <td>ATM,NBN,BRCA2,RAD51</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>TP53,ESR1</td>
    </tr>
    <tr>
      <th>Cardiac arrhythmia</th>
      <th>intercellular communication impairment</th>
      <td>ANK2,AKAP9,CACNA1C,CACNB2</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Cataract</th>
      <th>degradation of proteolytic systems</th>
      <td>WFS1</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>MAF</td>
    </tr>
    <tr>
      <th rowspan="7" valign="top">Charcot-marie-tooth disease</th>
      <th>accumulation of reactive oxygen species</th>
      <td>AIFM1,SURF1</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>LMNA</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>VCP</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>AIFM1,PMP22,KIF1B</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>LMNA,VCP,AIFM1</td>
    </tr>
    <tr>
      <th>nuclear architecture impairment</th>
      <td>LMNA</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>LMNA</td>
    </tr>
    <tr>
      <th rowspan="15" valign="top">Colorectal cancer</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>AKT1,PIK3CA,APC</td>
    </tr>
    <tr>
      <th>TOR pathway dysregulation</th>
      <td>AKT1,PIK3CA</td>
    </tr>
    <tr>
      <th>accumulation of reactive oxygen species</th>
      <td>TP53,MT-CO1</td>
    </tr>
    <tr>
      <th>alterations in DNA methylation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>EP300</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>TP53,EP300</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>AKT1,CTNNB1,APC</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>TP53,AKT1,BAX</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>TP53,CTNNB1,FGFR3</td>
    </tr>
    <tr>
      <th>mitochondrial DNA instability</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>TP53,BUB1B,MLH3</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>TP53,CTNNB1,BRAF</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>AKT1,TLR4,TLR2</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>TP53,EP300,CTNNB1</td>
    </tr>
    <tr>
      <th rowspan="5" valign="top">Diabetes mellitus</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>INS,IRS1,PTPN1,IRS2,INSR,AKT2</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>WFS1</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>INS</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>INS,IL6</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>PPARG,HNF4A</td>
    </tr>
    <tr>
      <th rowspan="6" valign="top">Dilated cardiomyopathy</th>
      <th>changes in the extracellular matrix structure</th>
      <td>LAMA4</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>LMNA,GATAD1</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>PSEN1</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>LMNA</td>
    </tr>
    <tr>
      <th>nuclear architecture impairment</th>
      <td>LMNA</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>LMNA</td>
    </tr>
    <tr>
      <th rowspan="9" valign="top">Fanconi anemia</th>
      <th>accumulation of reactive oxygen species</th>
      <td>FANCC</td>
    </tr>
    <tr>
      <th>alterations in DNA methylation</th>
      <td>BRCA1</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>BRCA1,BRCA2</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>BRCA1</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>FANCG</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>BRCA1,BRCA2,ERCC4,FANCG,FANCL,FANCC</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>BRCA2</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>FANCC</td>
    </tr>
    <tr>
      <th>telomere attrition</th>
      <td>BRCA2,ERCC4</td>
    </tr>
    <tr>
      <th rowspan="6" valign="top">Gastric cancer</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>PIK3CA,APC</td>
    </tr>
    <tr>
      <th>TOR pathway dysregulation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>alterations in DNA methylation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>APC,CASP10</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>FGFR2,KRAS</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>FGFR2</td>
    </tr>
    <tr>
      <th rowspan="4" valign="top">Gastrointestinal stromal tumor</th>
      <th>accumulation of reactive oxygen species</th>
      <td>SDHC,MTHFR,MTRR,SDHB</td>
    </tr>
    <tr>
      <th>alterations in DNA methylation</th>
      <td>MTRR</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>MTHFR</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>FOLR1</td>
    </tr>
    <tr>
      <th rowspan="11" valign="top">Glioma</th>
      <th>accumulation of reactive oxygen species</th>
      <td>TP53,IDH1</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>BRCA2</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>TP53,PTEN</td>
    </tr>
    <tr>
      <th>mitochondrial DNA instability</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>TP53,BRCA2</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>TP53,PTEN,BRCA2</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>telomere attrition</th>
      <td>BRCA2</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>TP53,PPARG</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Hemolytic uremic syndrome</th>
      <th>degradation of proteolytic systems</th>
      <td>CFB,CFH</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>C3,C3AR1</td>
    </tr>
    <tr>
      <th rowspan="13" valign="top">Hepatocellular carcinoma</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>PIK3CA,APC,IGF2R</td>
    </tr>
    <tr>
      <th>TOR pathway dysregulation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>accumulation of reactive oxygen species</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>alterations in DNA methylation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>CTNNB1,APC</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>TP53,CTNNB1</td>
    </tr>
    <tr>
      <th>mitochondrial DNA instability</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>TP53</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>TP53,CTNNB1</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>TP53,CTNNB1</td>
    </tr>
    <tr>
      <th rowspan="6" valign="top">Hirschsprung disease</th>
      <th>accumulation of reactive oxygen species</th>
      <td>DPYD</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>CREBBP</td>
    </tr>
    <tr>
      <th>changes in the extracellular matrix structure</th>
      <td>FBN1</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>PLAU,RET</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>ZHX2</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>CREBBP</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Leigh syndrome</th>
      <th>accumulation of reactive oxygen species</th>
      <td>NDUFA9,SURF1,NDUFS3,NDUFS4</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>BCS1L,COX10</td>
    </tr>
    <tr>
      <th rowspan="8" valign="top">Leukemia, acute myeloid</th>
      <th>alterations in histone modifications</th>
      <td>JAK2</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>NPM1</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>TERT,CEBPA</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>KRAS</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>TERT,NPM1</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>TERT,NPM1</td>
    </tr>
    <tr>
      <th>telomere attrition</th>
      <td>TERT</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>JAK2,MLF1</td>
    </tr>
    <tr>
      <th rowspan="6" valign="top">Lung cancer</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>TOR pathway dysregulation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>accumulation of reactive oxygen species</th>
      <td>CYP2A6</td>
    </tr>
    <tr>
      <th>alterations in DNA methylation</th>
      <td>PIK3CA</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>KRAS</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>BRAF</td>
    </tr>
    <tr>
      <th rowspan="4" valign="top">Macular degeneration, age-related</th>
      <th>changes in the extracellular matrix structure</th>
      <td>FBLN5</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>HTRA1,C2,CFB,CFH</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>APOE,CX3CR1</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>C3,TLR4</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Malaria, susceptibility to</th>
      <th>accumulation of reactive oxygen species</th>
      <td>HBB,G6PD</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>TNF,TIRAP</td>
    </tr>
    <tr>
      <th rowspan="8" valign="top">Mental retardation, autosomal dominant</th>
      <th>alterations in DNA methylation</th>
      <td>EHMT1</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>DYRK1A,EHMT1</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>EHMT1,SMARCA4,SMARCE1</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>CTNNB1</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>CTNNB1</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>PPP2R1A</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>CTNNB1</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>CTNNB1,DEAF1</td>
    </tr>
    <tr>
      <th rowspan="8" valign="top">Myocardial infarction, susceptibility to</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>ITGB3</td>
    </tr>
    <tr>
      <th>accumulation of reactive oxygen species</th>
      <td>GCLC</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>ESR1</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>LRP8,ACE</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>GCLC,GCLM</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>LRP8</td>
    </tr>
    <tr>
      <th>stem cell exhaustion</th>
      <td>ESR1,ACE</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>ESR1</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Obesity</th>
      <th>AMPK pathway dysregulation</th>
      <td>ADRB2</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>PPARG,ADRB2</td>
    </tr>
    <tr>
      <th rowspan="8" valign="top">Parkinson disease</th>
      <th>accumulation of reactive oxygen species</th>
      <td>PARK7,SNCA</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>PARK7</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>UCHL1,HTRA2,PARK7</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>MAPT,HTRA2,PARK7,SNCA</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>UCHL1,MAPT,SNCA,NR4A2</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>PARK7</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>PARK7</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>TBP,NR4A2</td>
    </tr>
    <tr>
      <th rowspan="7" valign="top">Prostate cancer</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>AR</td>
    </tr>
    <tr>
      <th>alterations in histone modifications</th>
      <td>BRCA2</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>PTEN,AR</td>
    </tr>
    <tr>
      <th>nuclear DNA instability</th>
      <td>BRCA2</td>
    </tr>
    <tr>
      <th>senescent cells accumulation</th>
      <td>PTEN,BRCA2</td>
    </tr>
    <tr>
      <th>telomere attrition</th>
      <td>BRCA2</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>AR</td>
    </tr>
    <tr>
      <th rowspan="3" valign="top">Retinitis pigmentosa</th>
      <th>accumulation of reactive oxygen species</th>
      <td>CYGB</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>TOPORS</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>TOPORS</td>
    </tr>
    <tr>
      <th rowspan="8" valign="top">Schizophrenia</th>
      <th>INS/IGF-1 pathway dysregulation</th>
      <td>AKT1</td>
    </tr>
    <tr>
      <th>TOR pathway dysregulation</th>
      <td>AKT1</td>
    </tr>
    <tr>
      <th>accumulation of reactive oxygen species</th>
      <td>MTHFR</td>
    </tr>
    <tr>
      <th>chromatin remodeling</th>
      <td>MTHFR</td>
    </tr>
    <tr>
      <th>degradation of proteolytic systems</th>
      <td>AKT1</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>AKT1</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>COMT,HTR2A,SYN2</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>AKT1</td>
    </tr>
    <tr>
      <th rowspan="4" valign="top">Spastic paraplegia</th>
      <th>impairment of proteins folding and stability</th>
      <td>HSPD1</td>
    </tr>
    <tr>
      <th>impairment of the mitochondrial integrity and biogenesis</th>
      <td>HSPD1</td>
    </tr>
    <tr>
      <th>intercellular communication impairment</th>
      <td>PLP1</td>
    </tr>
    <tr>
      <th>sterile inflammation</th>
      <td>PLP1</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Spinocerebellar ataxia</th>
      <th>intercellular communication impairment</th>
      <td>CACNA1A,PRKCG</td>
    </tr>
    <tr>
      <th>transcriptional alterations</th>
      <td>TBP</td>
    </tr>
  </tbody>
</table>